BB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis | PeerJ |  | 2021 | 375 | 160 | ||
| More evidence for dolutegravir as first-line ART for all | The Lancet HIV | | 2020 | 200 | 42 | ||
| Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection | The Journal of Infectious Diseases | | 2020 | 250 | 211 | ||
| All-Cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (SCCS) | Open Forum Infectious Diseases | | 2020 | 389 | 201 | ||
| Modelling the impact of different testing strategies for HCV infection in switzerland | Journal of virus eradication | | 2019 | 435 | 127 | ||
| Vaccination anti-HPV: mise à jour 2019 pour la consultation | Swiss Medical Forum | | 2019 | 458 | 477 | ||
| Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study | PLOS ONE | | 2019 | 469 | 227 | ||
| Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction | International Journal of Cancer | | 2019 | 312 | 294 | ||
| Non-inferiority of simplified dolutegravir monotherapy compared to continued combination antiretroviral therapy that was initiated during primary HIV infection: a randomized, controlled, multi-site, open-label, non-inferiority trial | Clinical Infectious Diseases | | 2019 | 406 | 205 | ||
| Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? | Clinical Infectious Diseases | | 2019 | 542 | 190 | ||
| Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland. A Comprehensive Mathematical Model of the Swiss HCV Epidemic | | 2018 | 610 | 190 | |||
| New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis | Tropical Medicine & International Health | | 2017 | 583 | 290 | ||
| Trends in hepatitis C-related mortality in Switzerland | Journal of Hepatology | | 2017 | 1,256 | 864 | ||
| Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM | AIDS | | 2017 | 594 | 430 | ||
| Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations | PloS one | | 2016 | 636 | 574 | ||
| Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study | International journal of cancer | | 2016 | 697 | 362 | ||
| Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period | HIV medicine |  | 2016 | 514 | 0 | ||
| HIV-infected women in Europe: gender-specific needs and challenges | Antiviral therapy | 2013 | 632 | 0 | |||
| Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study | American journal of epidemiology | | 2013 | 684 | 0 | ||
| Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery | Journal of acquired immune deficiency syndromes | | 2013 | 763 | 0 | ||
| Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study | Antiviral therapy | | 2007 | 626 | 0 |
